GSK-3484862 targets DNMT1 for degradation in cells
Q. Chen, Y. Zeng, J. W. Hwang, B. Liu, N. Dai, I. R. Correa, M. R. Estecio, X. Zhang, M. A. Santos, T. Chen, X. Cheng
This paper shows that GSK-3484862 targets DNMT1 for degradation in cancer cells and mouse embryonic stem cells, leading to DNA hypomethylation without reducing DNMT1 mRNA levels.
NAR Cancer · May 17, 2023Peer-reviewedCancer Biology